Quorum Consulting News Feed

Quorum Presents Poster at ISPOR 15th Annual International Meeting

2010-02-25T17:49:00Z

Quorum sponsors 5th Forum on Medical Device and Diagnostics Reimbursement Strategies

2010-02-09T00:19:00Z

Quorum Consulting, Inc. is the proud sponsor of:

5th Forum on Medical Device and Diagnostics Reimbursement Strategies

Ensuring Favorable Coverage, Coding and Payment Decisions Based on Clinical and Health Economic Evidence

February 23 - 24, 2010
San Diego, CA

Marianne Laouri, Ph.D., Practice Leader for Health Economics and Analytic Services will be co-leading a workshop titled, “Develop a Health Economics Program Early in Your Commercialization Strategy.”

Workshop Objective:
Quantifying the overall economic benefits that your product brings to the healthcare system is an increasingly important part of positioning it for a positive coverage decision for any size company. Commercial and private payors want to understand the net benefit an innovation brings to the healthcare system and expect data that validates the ROI of using your product to be available upon request. In this workshop, explore the importance and integration of health economics early in a commercialization strategy, the development of effective health models and techniques for communicating value to payors.

Please contact Quorum if you have not registered for the conference and would like to benefit from a $300 discount for registration.

Quorum Presents Findings at the 2010 AACR-IASCL Meeting

2010-01-18T18:50:00Z

BIOMEDevice Forum

2009-12-11T21:33:00Z

Quorum Published in Topics in Stroke Rehabilitation

2009-11-30T20:31:00Z

Quorum is pleased to announce a recent publication entitled Costs and Rehabilitation Use of Stoke Survivors: A Retrospective Study of Medicare Beneficiaries in the September-October 2009 issue of Topic in Stroke Rehabilitation. Article Link

2009 BioExec Institute

2009-11-13T16:55:00Z

The BioExec Institute is an internationally-renowned executive program delivered by leaders in the industry for life sciences directors and VP-level managers searching for the keys to managing business trade-offs within a highly regulated and competitive industry. Delivered by industry specialists, including Deloitte LLP leaders and BioExec Institute faculty and alumni, the Institute offers attendees six-days of interactive programming from September through December 2009, including three evening networking receptions. Participants have unique opportunities to debate the strategies and tactics of business leadership within biopharma and will complete the program with invaluable insight and powerful networks to help them deliver bottom-line value in this growing industry.

Quorum Presentation at National Institute of Health Commercial Acceleration Program Kick Off Meeting

2009-11-05T21:40:00Z

The National Institute of Health Commercialization Program (NIH-CAP) is a nation wide program funded by NIH designed to assist a preselected group of the most promising SBIR Phase II-funded life science companies bring their technologies to market. The November 18 meeting will launch the 10 month long 2009-2010 NIH CAP. At the meeting Susan will discuss reimbursement strategy development and tactical planning methods and concepts that have been designed to ensure that participating companies have a successful CAP experience and outcome.

Nov. 18, 2009, 3:30-4:30pm
Marriott Marina Del Rey, Marina Del Rey, CA

Quorum Presentation Cited in Cancer Journal

2009-11-02T22:03:00Z

A recent study in Cancer cited findings from a Quorum presentation at the 2007 ASCO Breast Cancer Symposium. Referencing the ASCO presentation, the article states that up to 66% of eligible patients had no documentation of HER-2 testing in claims records. This critical finding suggests a need for more evidence to support decision-making on emerging diagnostic technologies in cancer care. Cancer 2009 and Her-2 Poster

Quorum Presentation at Astia “Doing it Right Program”

2009-10-31T22:50:00Z

Astia is a San Francisco-based accelerator dedicated to supporting women-led high growth start-ups in the life sciences, clean tech and high technology sectors. The “Doing it Right Program” is one of several Astia programs offered annually that are designed to support women-led start ups who want to become dominant players in their sectors. During her presentation Susan will review key reimbursement strategic decisions that start up companies need to determine prior to meeting with angels, VCs and Corporate Investors. Susan will also review a framework to help the companies make these important reimbursement decisions.

Microsoft, 835 Market Street, 7th floor, San Francisco 94123
November, 4, 2009, 10:30am-1pm

New Technology Add-on Payment (NTAP) for Inpatient Procedure

2009-08-06T16:46:01Z

Quorum helps a client navigate the CMS application process to secure additional payment to hospital customers for its technology, effective fiscal year 2010.
CMS Website

2009 APC Panel Meeting

2009-07-30T18:25:00Z

Nicole Coustier, Director of Payer Relations and Government Affairs, attends the hospital outpatient APC Panel meeting at CMS in Baltimore, Aug 5-7 2009.
CMS Website

Is a Consumer-Directed Strategy Right for Your Technology?

2009-06-29T18:33:00Z

Strategic investment and product development considerations need to incorporate both reimbursement and patient payment options.how to think about the consumer market in reimbursement strategies. If anyone wants to take a look, you can find it at this link: With the rise of consumer control in healthcare expenditures, many medical technology companies have focused their business strategies around out-of-pocket spending as opposed to third-party reimbursement. Through case studies, we identified three scenarios surrounding consumer-targeted business models. These include: targeting consumer payment for some indications of a product while getting covered by insurers for other indications; targeting consumers solely because of belief that coverage will not be granted; and attempting to get coverage, but forced to pursue out-of-pocket spending after failing. As a result of the recession, companies that rely only on consumers for revenue are threatened, but this does not mean that targeting this market is not a valid choice. Thinking strategically about how your product will be viewed by insurers and consumers and how to market it to these two groups is an extremely important business decision.

Application of Financial Analysis to Three Retina Practices

2009-06-23T19:33:00Z

In the June 2009 issue of Retinal Physician, President Kuo Tong participates in a round table discussion on the application of activity-based costing analyses to three retina practices. Quorum conducts the analysis for each practice to examine the profitability of core retina service lines or activities, highlighting the effects of changing practice patterns and reimbursement scenarios in the retina subspecialty.
Retinal Physician Website
Practice Efficiency CME Study PDF

The Sixth Annual Healthcare Unbound Conference & Exhibition

2009-06-22T18:15:00Z

Senior Consultant Barbara Santry, serves as the moderator for the panel discussion ‘Who Will Pay For Healthcare Unbound?’ The panel highlights how to negotiate the legacy definition of a covered service: i.e. a medically necessary service to diagnose or treat an illness.
Healthcare Unbound Brochure

MAGI Conference

2009-05-21T19:45:00Z

Director Nicole Coustier presents on the sponsors role in clinical trial reimbursement at the MAGI conference in Miami, FL , May 31-June 3, 2009

MAGI Website